AI doctors will be good at science but bad at business, and big talk with little action means even higher drugs prices: 10 healthcare predictions for 2026 from top investors
NegativeFinancial Markets
- Predictions for 2026 indicate that AI doctors will excel in scientific capabilities but struggle with business acumen, potentially leading to increased drug prices due to ineffective management strategies. This outlook follows a period marked by public health turmoil and significant funding cuts in healthcare.
- The implications of these predictions are substantial, as they suggest that while technological advancements in healthcare may improve patient outcomes, the financial viability of these innovations could be compromised, resulting in higher costs for consumers.
- This situation reflects broader concerns within the tech and healthcare sectors, where companies like OpenAI are also facing financial hurdles, raising questions about the sustainability of AI
— via World Pulse Now AI Editorial System
